Home/Filings/4/0000899243-16-027015
4//SEC Filing

BIODELIVERY SCIENCES INTERNATIONAL INC 4

Accession 0000899243-16-027015

CIK 0001103021operating

Filed

Aug 11, 8:00 PM ET

Accepted

Aug 12, 6:08 PM ET

Size

13.7 KB

Accession

0000899243-16-027015

Insider Transaction Report

Form 4
Period: 2016-08-11
Transactions
  • Exercise/Conversion

    Common Stock

    2016-08-11+15,000122,675 total
  • Exercise/Conversion

    Common Stock

    2016-08-11+17,500140,175 total
  • Exercise/Conversion

    Restricted Stock Units

    2016-08-1115,0000 total
    Exercise: $0.00From: 2016-08-11Exp: 2016-08-11Common Stock (15,000 underlying)
  • Sale

    Common Stock

    2016-08-11$2.57/sh16,000$41,120124,175 total
  • Exercise/Conversion

    Restricted Stock Units

    2016-08-1117,50017,500 total
    Exercise: $0.00From: 2016-08-11Common Stock (17,500 underlying)
Footnotes (4)
  • [F1]The shares of common stock were acquired by the Reporting Person as a result of the vesting of 15,000 Restricted Stock Units ("RSUs") granted to the Reporting Person on July 16, 2015 under the Issuer's 2011 Equity Incentive Plan, as amended.
  • [F2]The shares of common stock were acquired by the Reporting Person as a result of the vesting of one-half of the RSUs granted to the Reporting Person on June 30, 2016 under the Issuer's 2011 Equity Incentive Plan, as amended. The remaining RSUs under this grant will vest in the first open window following the Company's 2017 Annual Meeting of Stockholders.
  • [F3]The shares of common stock were sold to cover the Reporting Person's tax liability upon the vesting of RSUs.
  • [F4]On August 11, 2016, the Reporting Person sold an aggregate of 16,000 shares of the Issuer's Common Stock at a weighted average price of $2.57. The highest sale price for the Common Stock was $2.72 per share and the lowest sale price was $2.47 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Issuer

BIODELIVERY SCIENCES INTERNATIONAL INC

CIK 0001103021

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001103021

Filing Metadata

Form type
4
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 6:08 PM ET
Size
13.7 KB